Pricing Log in Create free account

Matinas Biopharma Holdings, Inc. (MTNB) vs SciSparc Ltd. (SPRC)

Matinas Biopharma Holdings, Inc. and SciSparc Ltd. are both Biotechnology companies. Matinas Biopharma Holdings, Inc. is the larger, with a market value of $1.1M against $880.0K — 1.3× the size. Across the 10 metrics below, Matinas Biopharma Holdings, Inc. leads on 5 and SciSparc Ltd. on 5.

Valuation

Metric MTNB SPRC Biotechnology median
P/E n/m n/m 10.60
P/S 0.12 n/m 9.40
P/B 0.30 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.04 0.13 0.66
EV/Sales (0.06) n/m 9.02
Earnings yield (1,403.30%) (17,380.49%) (32.88%)
Free cash flow yield (1,142.24%) (160,955,097.92%) (23.13%)

Profitability

Metric MTNB SPRC Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.28%) 0.00% (51.96%)
Return on assets (98.53%) 0.00% (46.06%)
Return on invested capital (419.27%) 0.00% 0.00%

Growth

Metric MTNB SPRC Biotechnology median
Revenue growth (TTM) 2,135.91% — 6.76%
EPS growth (last fiscal year) 59.84% 51.90% 29.88%
Revenue growth, 5-year CAGR 55.69% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MTNB SPRC Biotechnology median
Debt to equity 0.00 0.24 0.00
Current ratio 0.85 0.87 4.97
Net debt to EBITDA 0.62 0.52 1.01

Dividend

Metric MTNB SPRC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MTNB SPRC Biotechnology median
Market cap 1.14m 880.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack